- Report
- January 2024
- 216 Pages
United States
From €3565EUR$3,750USD£2,995GBP
- Drug Pipelines
- November 2023
- 30 Pages
United States
From €2614EUR$2,750USD£2,196GBP
- Report
- August 2022
- 30 Pages
Global
From €2614EUR$2,750USD£2,196GBP
- Report
- March 2022
- 324 Pages
Global
From €9031EUR$9,500USD£7,587GBP
Dsuvia is an analgesic drug used to treat moderate to severe pain. It is a sublingual tablet that is administered under the tongue and is absorbed directly into the bloodstream. It is a Schedule II controlled substance and is only available through a restricted program. Dsuvia is a powerful opioid analgesic that is five to ten times more potent than fentanyl. It is intended for use in adults in a medically supervised setting, such as a hospital or emergency department. It is not intended for use at home or for chronic pain management.
Dsuvia is part of a larger market of analgesics, which includes both prescription and over-the-counter medications. Common prescription analgesics include opioids, such as morphine and oxycodone, as well as non-opioid medications, such as ibuprofen and acetaminophen. Over-the-counter analgesics include ibuprofen, acetaminophen, and aspirin.
Some companies in the analgesic market include Pfizer, Johnson & Johnson, GlaxoSmithKline, Merck, and Novartis. Show Less Read more